Mallinckrodt boosts hospitals platform with Therakos

Add to My Stories Print page Add to Favourites

The highly acquisitive biopharmaceutical group Mallinckrodt has looked to boost growth further with another purchase, in the form of the US-based immunotherapy company Therakos. The acquisition of Therakos – which…